MAM
Kyoorius Announces Speakers for Kyoorius Designyatra, 2014
MUMBAI: Sowing the seeds for great ideas to flourish and pushing people to chart their own paths is what Kyoorius Designyatra is known for.
Kyoorius continues its mission to facilitate by fueling inspiration for the creative industry by providing a platform that brings radical and divergent ideas into focus, and has announced the speakers’ lineup for IAA Kyoorius Digiyatra and Kyoorius Designyatra 2014. It includes a diverse pool of creative minds from India and the globe, which will engage delegates in stimulating discussions both on and off stage.
IAA Kyoorius Digiyatra is an entire day dedicated to all things digital, and will be held on 11th September. Delegates can expect to hear from the likes of:
1. Dhairya Dand – Designer, Researcher & Artist at MIT Media Lab
2. Elizabeth McGuane – Content Strategist & User Experience Designer
3. Fernanda ‘Fefa’ Romano – Chief Creative Officer, Naked Brazil
4. Gaston Legorburo – Executive Director & Worldwide Chief Creative Officer SapientNitro
5. Christian Etter – Founder of Etter Studio
6. Tim Malbon – Founding partner of Made by Many
Designyatra, which takes place from 12th to 13th of September, will offer delegates the opportunity to imbibe knowledge and insights from some of the most innovative thinkers and entrepreneurs, share their experiences and have meaningful face-to-face interactions with peers.
Speakers include:
1. Ajaz Ahmed – CEO and founder of AKQA
2. David Berman – Founder, David Berman Communications
3. David Law – Founder, Co-Owner, Executive Strategic Creative Director, SomeOne
4. David Sherwin – Fellow, Frog Design
5. Ivan Chermayeff – Principal, Chermayeff & Geismar & Haviv
6. Liam Paton – Co-Founder & Music Director, Silent Studios
7. Michael Wolff – Founder, Michael Wolff & Company
8. Morihiko Hasebe – Executive Creative Director, Hakuhodo Inc.
9. Jonathan Ford – Founding Partner & Chief Creative Officer, Pearlfisher
10. Mat Heinl – Chief Executive Officer, Moving Brands
11. Natasha Jen – Partner, Pentagram
12. Nathan Prince – Co-Founder & Creative Director, Silent Studios
13. Simon Manchipp – Founder, Co-Owner, Executive Strategic Creative Director, SomeOne
14. Stalin K – Director & Managing Trustee, Video Volunteers
15. Todd Rovak – Managing Partner, Fahrenheit 212
Both Designyatra & Digiyatra will be moderated by Patrick Burgoyne – Editor, Creative Review
Rajesh Kejriwal, Founder CEO, Kyoorius said, “Year after year our aim has always been to exceed our own expectations and this year too we have aimed to get the best of the best at Designyatra. Our speakers will discuss their approach to design and share their insight into ideas that are taking the world by storm in design, digital, branding, communication and more.”
This year, Kyoorius Designyatra will be held from 11th to the 13th of September at Grand Hyatt, Goa and will be attended 1300 delegates. The theme is What if?, which will be explored through a variety of formats such as talks, breakout sessions, portfolio reviews and more.
Brands
Sun Pharma to acquire Organon in $11.75 billion deal at $14 per share
Acquisition to create $12.4 billion pharma giant with global scale and biosimilars push
MUMBAI: Sun Pharmaceutical Industries Limited has signed a definitive agreement to acquire Organon & Co. in an all-cash deal valued at $11.75 billion, marking one of the largest cross-border pharma acquisitions by an Indian firm.
Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, with Sun Pharma set to acquire 100 per cent of the company’s outstanding shares. The transaction, approved by the boards of both companies, is expected to close in early 2027, subject to regulatory approvals and shareholder consent.
The deal significantly expands Sun Pharma’s global footprint and strengthens its position across women’s health, biosimilars, and branded generics. The combined entity is projected to generate revenues of around $12.4 billion, placing it among the top 25 pharmaceutical companies globally.
Organon, which was spun off from Merck in 2021, brings a portfolio of over 70 products spanning women’s health and general medicines, with operations across more than 140 countries. Its established presence in key markets such as the US, Europe, and China complements Sun Pharma’s existing strengths and growth ambitions.
Sun Pharmaceutical Industries Limited executive chairman Dilip Shanghvi said, “This transaction represents a significant opportunity for Sun Pharma to build on its vision of reaching people and touching lives. Organon’s portfolio, capabilities and global reach are highly complementary to our own.”
Sun Pharmaceutical Industries Limited managing director Kirti Ganorkar added, “This transaction is a logical next step in strengthening Sun Pharma’s global business. Together, we will become a partner of choice for acquiring and launching new products.”
From Organon’s side, Organon & Co. executive chair Carrie Cox noted, “This all-cash transaction offers compelling and immediate value to Organon stockholders, while positioning the business for continued growth under Sun Pharma.”
Strategically, the acquisition gives Sun Pharma entry into the global biosimilars space as a top 10 player and strengthens its innovative medicines portfolio, which is expected to contribute around 27 per cent of combined revenues. The deal is also expected to nearly double EBITDA and cash flow, supporting long-term deleveraging and investment capacity.
Sun Pharma plans to fund the acquisition through a mix of internal accruals and committed financing from global banks, while maintaining focus on disciplined integration and operational continuity post-merger.
If completed as planned, the deal signals a clear shift in India’s pharmaceutical ambitions, from scale at home to leadership on the global stage, with Sun Pharma positioning itself as a more diversified and innovation-led healthcare powerhouse.
